Author:
Thunshelle Connor P.,Koay Eugene J.,Hill Colin,Alfano Catherine M.,Herman Joseph M.
Publisher
Springer International Publishing
Reference97 articles.
1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
2. Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open. 2021;4(4):e214708.
3. Revicki DA, Gnanasakthy A, Weinfurt K. Documenting the rationale and psychometric characteristics of patient reported outcomes for labeling and promotional claims: the PRO Evidence Dossier. Qual Life Res. 2007;16(4):717–23.
4. Karnofsky DA, Burchenal JH. Evaluation of chemotherapeutic agents. In: MacLeod CM, editor. The clinical evaluation of chemotherapeutic agents in cancer. New York: Columbia University Press; 1949. p. 191–205.
5. Carrato A, et al. A systematic review of the burden of pancreatic cancer in europe: real-world impact on survival, quality of life and costs. J Gastrointest Cancer. 2015;46(3):201–11.